2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet ...
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet ...
Jan 1, 2018 · 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur J Cardiothorac ...
Aug 26, 2017 · This document provides recommendations on DAPT in patients with coronary artery disease (CAD). Chapters are devoted to DAPT and percutaneous ...
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Marco Valgimigli ,.
Special article. Special article 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Marco ...
The following material was adapted from the 2017 ESC focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease in collaboration with EACTS ( ...
PDF | On Aug 26, 2017, Marco Valgimigli and others published 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in ...
People also ask
What are the ESC guidelines for DAPT?
What are the current guidelines for dual antiplatelet therapy?
What is the global antiplatelet sales trend a focus on P2Y12 inhibitors from 2008 to 2018?
What is dual antiplatelet therapy for coronary artery disease?
2017 ESC Focused Update on DAPT in Coronary Artery Disease, developed in collaboration with EACTS. (European Heart Journal 2017 - doi:10.1093/eurheartj/ehx419).
This paper aims to review the ACC/AHA and ESC updates for DAPT to delineate common domains, consistent messages, and differences in recommended management ...
People also search for
